Search Results - "Jolicoeur, Marjory"

Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma by Provencher, Sawyna, Oehler, Christoph, Lavertu, Sophie, Jolicoeur, Marjory, Fortin, Bernard, Donath, David

“…To evaluate quality of life (QOL) and outcome of patients with anal carcinoma treated with short split-course chemoradiation (CRT). From 1991 to 2005, 58…”
Get full text

Evaluation of Prognostic Factors Associated with HDR Brachytherapy Induced Prostatitis by Derashodian, Talar, MD, Wakil, George, MD, Mondat, Maryse, MSc, Berbiche, Djamal, PhD, Van Nguyen, Thu, MD, Lymberiou, Timothy, MD, Jolicoeur, Marjory, MD

Get full text

The Influence of Dosimetry on Acute Urinary Toxicity in HDR Prostate Brachytherapy by El-Bared, Nancy, MD, Derashodian, Talar, MD, Wakil, George, MD, Mondat, Maryse, MSc, Van Nguyen, Thu, MD, Lymberiou, Timothy, MD, Berbiche, Djamal, PhD, Jolicoeur, Marjory, MD

Get full text

Toxicity report of once weekly radiation therapy for low-risk prostate adenocarcinoma: preliminary results of a phase I/II trial by Menkarios, Cathy, Vigneault, Éric, Brochet, Nicolas, Nguyen, David H A, Bahary, Jean-Paul, Jolicoeur, Marjory, Beauchemin, Marie-Claude, Villeneuve, Hugo, Van Nguyen, Thu, Fortin, Bernard, Lambert, Carole

“…Increasing clinical data supports a low α/β ratio for prostate adenocarcinoma, potentially lower than that of surrounding normal tissues. A hypofractionated,…”
Get full text

36 Assessing Radiation Therapy Needs in Francophone Lmics: Overcoming Language Barriers for Equitable Cancer Care by Harris, Philippe, Gaudet, Marc, Naoun, Lilia, Pignol, Jean-Philippe, Jolicoeur, Marjory, Abdel-Wahab, May, Bourque, Jean-Marc

Get full text

High-dose-rate interstitial brachytherapy and lumpectomy as a second conservative treatment for local recurrences of breast cancer by Jolicoeur, Marjory, M.D, David, Sandrine, M.Sc, Delvecchio, Pierre, M.D, Rousseau, Pierre, M.D, Mondat, Maryse, M.Sc

Get full text

Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy by Robin, Sophie, Jolicoeur, Marjory, Palumbo, Samuel, Zilli, Thomas, Crehange, Gilles, De Hertogh, Olivier, Derashodian, Talar, Sargos, Paul, Salembier, Carl, Supiot, Stéphane, Udrescu, Corina, Chapet, Olivier

“…Prostate bed (PB) irradiation is considered the standard postoperative treatment after radical prostatectomy (RP) for tumors with high-risk features or…”
Get full text

Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU) by De Hertogh, Olivier, Le Bihan, Guillaume, Zilli, Thomas, Palumbo, Samuel, Jolicoeur, Marjory, Crehange, Gilles, Derashodian, Talar, Roubaud, Guilhem, Salembier, Carl, Supiot, Stéphane, Chapet, Olivier, Achard, Verane, Sargos, Paul

“…PURPOSEClinical target volume (CTV) delineation for pelvic lymph nodes in prostate cancer is currently based on 3 consensus guidelines with some inherent…”
Get full text

Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial by Niazi, Tamim, Nabid, Abdenour, Malagon, Talia, Bettahar, Redouane, Vincent, Linda, Martin, Andre-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Tsui, James Man Git, Mohiuddin, Md

“…The low α\β ratio of 1.2 to 2 for prostate cancer (PCa) suggests high radiation-fraction sensitivity and predicts a therapeutic advantage of hypofractionated…”
Get full text

Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial by Niazi, Tamim, Nabid, Abdenour, Malagon, Talia, Tisseverasinghe, Steven, Bettahar, Redouane, Dahmane, Rafika, Martin, Andre-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md

Get full text

Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU) by Ah-Thiane, Loic, Sargos, Paul, Chapet, Olivier, Jolicoeur, Marjory, Terlizzi, Mario, Salembier, Carl, Boustani, Jihane, Prevost, Célia, Gaudioz, Sonya, Derashodian, Talar, Palumbo, Samuel, De Hertogh, Olivier, Créhange, Gilles, Zilli, Thomas, Supiot, Stéphane

“…Illustration of the concerns when managing a patient with BCR, and the main relevant trials addressing these issues. [Display omitted] •- Biochemical…”
Get full text

The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients by Khriguian, Julia, Tsui, James Man Git, Vaughan, Rachel, Kucharczyk, Michael Jonathan, Nabid, Abdenour, Bettahar, Rédouane, Vincent, Linda, Martin, André-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md, Niazi, Tamim

“…Long-term androgen deprivation therapy has been associated with decreased bone mineral density in men with prostate cancer. Some evidence suggests that there…”
Get full text

MRI-guided prostate brachytherapy dose escalation to the dominant intraprostatic lesions: A retrospective analysis of urinary toxicity and biochemical response by Wakil, George, Côté, Nicolas, Lymberiou, Timothy, Aaron, Lorne, Antebi, Elie, Arjane, Philippe, Derashodian, Talar, Do, Vien, Jolicoeur, Marjory, Nachabe, Mahmoud, Van Nguyen Huynh, Thu, Duguay-Drouin, Patricia

“…Abstract only 47 Background: Magnetic resonance imaging (MRI) allows for delineation of the dominant intraprostatic lesions (DIL) thus minimizing the risk of a…”
Get full text

Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation Therapy by Le Guévelou, Jennifer, Zilli, Thomas, Ferretti, Ludovic, Beuzit, Luc, De Hertogh, Olivier, Palumbo, Samuel, Jolicoeur, Marjory, Crehange, Gilles, Derashodian, Talar, De Crevoisier, Renaud, Chapet, Olivier, Terlizzi, Mario, Supiot, Stéphane, Salembier, Carl, Sargos, Paul

“…The occurrence of genitourinary (GU) toxicity is a common adverse event observed after external beam radiation therapy (EBRT) for prostate cancer (PCa). Recent…”
Get full text

115 Optimal Hypofractionated Rectal Dose-Volume Constraint from the Prostate Cancer Patients of the PCS V Trial by Tsui, James Man Git, Khriguian, Julia, Kucharczyk, Michael Jonathan, Nabid, Abdenour, Bettahar, Redouane, Vincent, Linda Suzanne, Martin, Andre-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md, Niazi, Tamim M.

Get full text

125 Rectal Wall Versus Whole Rectum Dose: Which Volume Better Predicts Gastrointestinal Toxicity from Prostate External Beam Radiotherapy? by Khriguian, Julia, Tsui, James Man Git, Kucharczyk, Michael Jonathan, Nabid, Abdenour, Bettahar, Redouane, Vincent, Linda Suzanne, Martin, André-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md, Niazi, Tamim Mohammad

Get full text

199 The Clinical Significance of Bone Mineral Density Changes Following Long Term Androgen Deprivation Therapy in Prostate Cancer Patients Enrolled in the PCS V Trial by Vaughan, Rachel, Tsui, James Man Git, Kucharczyk, Michael Jonathan, Nabid, Abdenour, Bettahar, Rédouane, Vincent, Linda Suzanne, Martin, André-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md, Niazi, Tamim

Get full text

Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate Cancer Study 5, a Groupe de Radio-oncologie Génito-urinaire du Quebec-led Phase 3 Trial by Niazi, Tamim, Nabid, Abdenour, Malagon, Talia, Tisseverasinghe, Steven, Bettahar, Redouane, Dahmane, Rafika, Martin, Andre-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Mohiuddin, Md

“…Prostate Cancer Study 5 (PCS5) compared conventional fractionated radiotherapy (CFRT) with hypofractionated radiotherapy (HFRT) in high-risk prostate cancer…”
Get full text

Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy by Jolicoeur, Marjory, Racine, Marie-Lynn, Trop, Isabelle, Hathout, Lara, Nguyen, David, Derashodian, Talar, David, Sandrine

“…Abstract Purpose To evaluate the feasibility of supine breast magnetic resonance imaging (MR) for definition and localization of the surgical bed (SB) after…”
Get full text

Hypofractionated, dose escalation radiotherapy for high-risk prostate cancer: The primary endpoint of a group led phase III trial. (PCS5) by Niazi, Tamim, Nabid, Abdenour, Bettahar, Redouane, Vincent, Linda S., Martin, Andre-Guy, Jolicoeur, Marjory, Yassa, Michael, Barkati, Maroie, Igidbashian, Levon, Bahoric, Boris, Archambault, Robert, Villeneuve, Hugo, Tsui, James M, Mohiuddin, MD

“…Abstract only 123 Background: The low α\β ratio of prostate cancer (PCa), 1.5-2, suggests high radiation-fraction sensitivity and predicts a therapeutic…”
Get full text